Stocksigma LogoStocksigma Logo

Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion

Amanta Healthcare reported a 17.3% YoY revenue rise to ₹83.13 crore in Q2FY27, while EBITDA increased 21.9% YoY to ₹17.95 crore, expanding margins by ~80

Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion

Amanta Healthcare Ltd · Press Release · 04 Nov 2026, 4:58 pm

Amanta Healthcare Reports Strong Q2FY27 Results With Operational Expansion Amanta Healthcare reported a 17.3% YoY revenue rise to ₹83.13 crore in Q2FY27, while EBITDA increased 21.9% YoY to ₹17.95 crore, expanding margins by ~80 bps to 21.6%. PAT jumped to ₹4.86 crore from ₹1.21 crore in Q2FY26. H1FY27 revenue reached ₹151.94 crore with PAT of ₹8.17 crore. The commissioned SteriPort Line 3 expanded capacity by 75% to 11.6 crore bottles, targeting ~₹60 crore FY27 revenue contribution. Further Small Volume Parenteral capacity expansion is targeted for Q1FY28, while a 10.8 MW captive solar plant yields ~₹9 crore annual savings.

Original exchange filing (PDF)

More announcements from Amanta Healthcare Ltd

All Amanta Healthcare Ltd announcements